IgM, not IgG, a key for HIV vaccine.
Although HIV infections induce a very strong humoral immune reaction with various neutralization activities and a well-defined cellular immunity, HIV vaccine development based on traditional approaches failed. The fact that neither specific antibodies nor activated CD8+ cytotoxicity T-cells could provide primary protection in high risk populations raises the question concerning whether a specific vaccine is feasible. While the immune system as an intact defense system against HIV is ineffective or may even enhance the virus spread, a distinct small part of the system plays important role in delaying the progress of the disease. After carefully dissecting the different immune reactions against the virus, a new HIV vaccine strategy is indicated.
Yang
Quan-en
QE
D016915:AIDS Vaccines; D000917:Antibody Formation; D015195:Drug Design; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D007075:Immunoglobulin M / Q000276:immunology*; D014765:Viral Vaccines
D016915:AIDS Vaccines; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014765:Viral Vaccines